Cover Image
市場調查報告書

認知障礙:全球臨床實驗檢討

Cognitive Impairment Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 306656
出版日期 內容資訊 英文 435 Pages
訂單完成後即時交付
價格
Back to Top
認知障礙:全球臨床實驗檢討 Cognitive Impairment Global Clinical Trials Review, H1, 2017
出版日期: 2017年06月30日 內容資訊: 英文 435 Pages
簡介

本報告提供認知障礙相關的臨床研究最新趨勢分析,提供您疾病·治療方法概要,G7各國及E7(新興7國)的臨床實驗狀況,地區、Phase、階段別的進行狀況,並彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

目錄

簡介

  • 認知障礙
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區前五名國家的臨床實驗數量
    • 歐洲前五名國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東及非洲的前五國的臨床實驗數量
    • 南美主要國家的臨床實驗數量

G7各國的臨床實驗數量:中樞神經系統臨床實驗的認知障礙臨床實驗數量比例

G7各國的臨床實驗數量:Phase別

G7各國的臨床實驗數量:各進展狀況

E7(新興7國)的臨床實驗數量:中樞神經系統的認知障礙臨床實驗數量比例

E7(新興7國)的臨床實驗數量:Phase別

E7(新興7國)的臨床實驗數量:各進展狀況

臨床實驗數量:Phase別

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的受驗者人數

贊助商類別的臨床實驗數量

有潛力的贊助商

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • Pfizer Inc.
    • Novartis AG
    • Johnson & Johnson
    • Eli Lilly and Company
    • Merck & Co., Inc.
    • Eisai
    • AbbVie Inc.
    • 武田藥品
    • Shire Plc
    • GlaxoSmithKline plc
  • 有代表性的研究機關醫院臨床實驗概要
    • U.S. Department of Veterans Affairs
    • University of Washington
    • Charite - Universitatsmedizin Berlin
    • University Hospital Basel
    • National Institute on Aging
    • Vanderbilt University
    • University of Pennsylvania
    • Emory University
    • University Hospital, Angers
    • National Institute of Mental Health

5個有代表性的臨床實驗簡介

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4317CTIDB

GlobalData's clinical trial report, "Cognitive Impairment Global Clinical Trials Review, H1, 2017" provides an overview of Cognitive Impairment clinical trials scenario. This report provides top line data relating to the clinical trials on Cognitive Impairment. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Five Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Cognitive Impairment to Central Nervous System Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 18
  • Clinical Trials in G7 Countries by Trial Status 19
  • Clinical Trials by E7 Countries: Proportion of Cognitive Impairment to Central Nervous System Clinical Trials 21
  • Clinical Trials by Phase in E7 Countries 23
  • Clinical Trials in E7 Countries by Trial Status 24
  • Clinical Trials by Phase 26
  • In Progress Trials by Phase 27
  • Clinical Trials by Trial Status 28
  • Clinical Trials by End Point Status 30
  • Subjects Recruited Over a Period of Time 31
  • Clinical Trials by Sponsor Type 32
  • Prominent Sponsors 33
  • Top Companies Participating in Cognitive Impairment Therapeutics Clinical Trials 35
  • Prominent Drugs 37
  • Clinical Trial Profile Snapshots 38

Appendix 433

  • Abbreviations 433
  • Definitions 433
  • Research Methodology 434
  • Secondary Research 434
  • About GlobalData 435
  • Contact Us 435
  • Source 435

List of Tables

List of Tables

  • Cognitive Impairment Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Cognitive Impairment Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Cognitive Impairment Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
  • Cognitive Impairment Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Cognitive Impairment Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Cognitive Impairment Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
  • Cognitive Impairment Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
  • Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 17
  • Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
  • Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 22
  • Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
  • Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25
  • Cognitive Impairment Therapeutics, Global, Clinical Trials by Phase, 2017* 26
  • Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 27
  • Cognitive Impairment Therapeutics, Global, Clinical Trials by Trial Status, 2017* 29
  • Cognitive Impairment Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
  • Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 32
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 34
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 36
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37

List of Figures

List of Figures

  • Cognitive Impairment Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Cognitive Impairment Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Cognitive Impairment Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
  • Cognitive Impairment Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Cognitive Impairment Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Cognitive Impairment Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14
  • Cognitive Impairment Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
  • Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 16
  • Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
  • Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 21
  • Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
  • Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24
  • Cognitive Impairment Therapeutics, Global, Clinical Trials by Phase (%), 2017* 26
  • Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 27
  • Cognitive Impairment Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28
  • Cognitive Impairment Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
  • Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 32
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37
  • GlobalData Methodology 434
Back to Top